About
Newfund is one of the most dynamic seed-stage investment funds, managing $400M in assets under management.
Newfund has had a continuous presence in the United States since 2014. The fund has built a significant portfolio of startups, mainly in technology and healthcare, with around forty US investments today. Newfund also supports many French startups in their US expansion, particularly on go-to-market, sales, and local structuring topics. This long-standing presence has enabled the firm to build a strong network of entrepreneurs, investors, and partners, especially in the Bay Area, in support of portfolio companies and Newfund’s long-term strategy.
Newfund Heka is Newfund’s sector-focused BrainTech fund, investing from early stage to Series A in companies at the intersection of neuroscience and artificial intelligence. The fund supports founders building solutions to address major challenges in brain health. Its portfolio includes AI-Stroke, Diagnoly, Inside Therapeutics, Nurea, Oria Biosciences, Raidium, Reev, and Soihtu DTx.